Where does Restor3d, Inc. rank among US patent assignees?

According to USPTO PatentsView (2015–2025 granted utility patents), Restor3d, Inc. ranks #11,788 of 49,997 assignees by granted-patent volume, the same sort as the companies listing and top-holders ranking. See /methodology/#corpus-placement.

How many patents does Restor3d, Inc. hold?

Restor3d, Inc. holds 26 US utility patents granted between 2019 and 2025, spanning 10 technology areas.

What is Restor3d, Inc.'s Innovation Score?

Restor3d, Inc. has an Innovation Score of 36.2 out of 100 (top 47% of the corpus). This composite metric weighs portfolio volume (40%), grant velocity (20%), technology breadth (25%), and claim depth (15%).

Is Restor3d, Inc.'s patent grant rate increasing or decreasing?

Restor3d, Inc.'s recent grant velocity is +400% compared to the prior five-year period (grant years, not application filing dates). This indicates accelerating grant output.

What does claim depth mean for Restor3d, Inc.'s patents?

Restor3d, Inc.'s patents average 9.5 claims each. This is an aggregate descriptive count from the grant record; it does not establish claim scope, legal strength, enforceability, or design-around risk.

How is the Restor3d, Inc. patent data sourced?

All patent data comes from USPTO PatentsView, a public research dataset maintained by the United States Patent and Trademark Office covering US granted utility patents from 2015 to 2025.

USPTO 2015–2025 USPTO PatentsView US Corporation

Restor3d, Inc.

Q: What technology areas does Restor3d, Inc. focus on?

Restor3d, Inc.'s top technology area is A61F (Filters Implantable Into Blood VESSELS; PROSTHESES; Devices Providing Patency TO, OR Preventing Collapsing OF, Tubular Structures OF THE Body, e.g. STENTS; Orthopaedic, Nursing OR Contraceptive DEVICES; FOMENTATION; Treatment OR Protection OF Eyes OR EARS; Bandages, Dressings OR Absorbent PADS; Firs) with 8 patents, ranking #786 of 3,082 assignees active in that subclass. Grants appear in 10 CPC subclasses total.

USPTO PatentsView assignee record - 26 granted patents across 10 technology areas, recorded in grant years 2019–2025. Grant-trend analysis is cross-referenced to USPTO Patent Public Search; it does not measure application filings, current R&D, or legal strength. Primary class: A61F (Filters Implantable Into Blood VESSELS; PROSTHESES; Devices Providing Patency TO, OR Preventing Collapsing OF, Tubular Structures OF THE Body, e.g. STENTS; Orthopaedic, Nursing OR Contraceptive Device).

Compiled by PlainPatent · May 15, 2026

RSS updates for this company

Explore the portfolio See the ranking

The verdict

According to USPTO PatentsView, Restor3d ranks #11,788 of 49,997 tracked US assignees by granted-patent volume, with 26 patents across 10 technology areas.

#11,788
of 49,997 US assignees by volume: Top 47%
by Innovation Score (36.2/100): 9.5
avg claims per patent: +400%
grant velocity, last 5 yrs

USPTO PatentsView assignee plate

Corpus R11788 · US Corporation #11,788 · 26 grants

GRANTS-SMALL · UPPER-Q · PHOTO-FINISH · CPC-FOCUS · INNOV-THIN · CLAIMS-PAR · TYPE-USCORP · VEL-SURGE · BOOK-FULL

GRANTS-SMALL 26 grants
UPPER-Q #11,788/49,997
PHOTO-FINISH Qingdao University…
CPC-FOCUS A61F · 10 areas
INNOV-THIN 36.2/100
CLAIMS-PAR 9.5 claims/avg
TYPE-USCORP US Corporation
VEL-SURGE +400% vel
BOOK-FULL 10/10 fields

Nearest grant-volume peer: Qingdao University of Science and Technology (±0 grants)

Instrument codes from this assignee’s USPTO PatentsView grant sheet: volume band, corpus rank, photo-finish peer, lead CPC, Innovation Score, claim depth, assignee type, velocity, and book completeness. Not a USPTO rating of patent strength.

How Restor3d’s 36.2 Innovation Score adds up

The same four weighted components behind every Innovation Score on PlainPatent: portfolio volume, grant velocity, technology breadth, and claim depth.

Volume 11.4 pts (31%) Velocity 7.9 pts (22%) Breadth 11.2 pts (31%) Claim depth 5.7 pts (16%)

Qualcomm Incorporated · highest

85
Express Scripts · near

36
Swatch · near

36
Cardioxyl Pharmaceut… · near

36
I C Medical · near

36
Restor3d · this assignee

36
3D Lighting… · lowest

7

What this shows Restor3d's Innovation Score is 36.2/100 (top 47% of the PatentsView-derived corpus). The chart places that score against the nearest Innovation Score peers plus corpus poles, not a reprint of the volume ranking.

Does more volume mean deeper claims for Restor3d?

Each dot is one of Restor3d’s 8 nearest volume peers (same corpus rank neighbourhood as the chart above), placed by total granted patents (horizontal) against average claims per patent (vertical). Restor3d’s own 9.5 claims/patent is at or below the 10.8 median for these volume peers. Volume here does not track with deeper claims; several lower-volume peers claim more thoroughly per patent.

Restor3d vs its 8 nearest volume peers: granted patents vs average claims per patent. Source: USPTO PatentsView.

Where Restor3d's grants concentrate

Restor3d, Inc. is a focused PatentsView assignee: 10 CPC subclasses with 30.8% of grants classified under A61F (Filters Implantable Into Blood VESSELS; PROSTHESES; Devices Providing Patency TO, OR Preventing Collapsing OF, Tubular Structures OF THE Body, e.g. STENTS; Orthopaedic, Nursing OR Contraceptive Device). Peak complete grant year is 2024 (7 grants) versus a trough of 1 in 2022. By volume, Restor3d sits between Qingdao University of Science and Technology and Rampart Communications, Inc..

Restor3d's three-year grant acceleration

Restor3d, Inc. shows 13 grants in 2022–2024 against only 11 in 2019–2021. That prior window is too thin for a growth multiple (rename and spin-out assignees look artificially high when the baseline is near zero), so PlainPatent withholds a ranked acceleration claim here.

Qingdao Universit…

26
Railblaza

26
Rapid Medical

26
Reestar Internati…

26
Revmedica

26
Roddie

26
Rosenberger

26
Rampart Communica…

26
Restor3d ◀

26

What this shows Restor3d holds 26 patents at rank #11,784, shown against the 8 assignees closest to it in grant volume rather than the industry's largest filers.

Companies ranked near Restor3d

By rank, the assignees closest to #11,784 in granted patent volume.

Leaders in A61F (Filters Implantable Into Blood Vessels)

Other assignees with the most granted patents in Restor3d's primary technology class.

Assignees with similar portfolio profiles

Two PlainPatent-derived peer sets for Restor3d, neither rank-band nor same-CPC leaders (those blocks stay above). In A61F (Filters Implantable Into Blood Vessels), Restor3d ranks #786 of 3,082 assignees by patent count in that subclass.

Similar innovation score

Nearest assignees by Innovation Score (36 here).

Cardioxyl Pharmaceuticals, Inc. 36 I.C. Medical, Inc. 36 Express Scripts, Inc. 36 Swatch Ltd. 36

Restor3d's Innovation Score vs. every tracked assignee

Composite of portfolio volume, grant velocity, technology breadth, and claim depth (0–100)

36 Top 47% higher than 53% of 49,997 US assignees

Each bar is a band; taller bars hold more US assignees. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count, share, and where it sits relative to this entry.

Source USPTO PatentsView, PlainPatent Innovation Score · 2015–2025

USPTO utility patent grants by year · 2019–2025

Grants by year

Teal-shaded recent years (2020–present) versus the 2019–2019 baseline. Full figures in the table below.

View data table

Restor3d, Inc. patent grants by year, 2015–2025
Year	Patents Granted	Share of Period
2019	4	15.4%
2020	2	7.7%
2021	5	19.2%
2022	1	3.8%
2023	5	19.2%
2024	7	26.9%
2025partial year	2	7.7%

Which technologies does Restor3d, Inc. patent most?

A61F - Filters Implantable Into Blood VESSELS; PROSTHESES; Devices Providing Patency TO, OR Preventing Collapsing OF, Tubular Structures OF THE Body, e.g. STENTS; Orthopaedic, Nursing OR Contraceptive DEVICES; FOMENTATION; Treatment OR Protection OF Eyes OR EARS; Bandages, Dressings OR Absorbent PADS; Firs 8

B33Y - Additive Manufacturing, i.e. Manufacturing OF Three-dimensional [3-D] Objects BY Additive Deposition, Additive Agglomeration OR Additive Layering, e.g. BY 3-D Printing, Stereolithography OR Selective Laser Sintering 6

A61B - DIAGNOSIS; SURGERY; Identification 5

G16H - Healthcare Informatics, i.e. Information AND Communication Technology [ICT] Specially Adapted FOR THE Handling OR Processing OF Medical OR Healthcare Data 3

B29L - Indexing Scheme Associated With Subclass B29c, Relating TO Particular Articles 2

B29C - Shaping OR Joining OF PLASTICS; Shaping OF Material IN A Plastic State, NOT Otherwise Provided FOR; After-treatment OF THE Shaped Products, e.g. Repairing 2

G05B - Control OR Regulating Systems IN GENERAL; Functional Elements OF Such SYSTEMS; Monitoring OR Testing Arrangements FOR Such Systems OR Elements 2

G06T - Image Data Processing OR Generation, IN General 2

A61L - Methods OR Apparatus FOR Sterilising Materials OR Objects IN GENERAL; Disinfection, Sterilisation OR Deodorisation OF AIR; Chemical Aspects OF Bandages, Dressings, Absorbent Pads OR Surgical ARTICLES; Materials FOR Bandages, Dressings, Absorbent Pads OR Surgical Articles 1

B29K - Indexing Scheme Associated With Subclasses B29b, B29c OR B29d, Relating TO Moulding Materials OR TO Materials FOR ; Moulds, ; Reinforcements, Fillers OR Preformed Parts, e.g. Inserts 1

Top 10 of 10 technology areas

More on this record

Data Source

USPTO PatentsView, US granted patents 2015–2025

View all rankings → How is Innovation Score calculated?

What to do with this data

Restor3d, Inc.'s patent record in context - here's where to go next.

Restor3d, Inc.'s lead technology class is A61F (Filters Implantable Into Blood VESSELS; PROSTHESES; Devices Providing Patency TO, OR Preventing Collapsing OF, Tubular Structures OF THE Body, e.g. STENTS; Orthopaedic, Nursing OR Contraceptive Device), 30.8% of its portfolio - see every assignee active in that class. Explore A61F
Ranked #11,788 of 49,997 tracked assignees by patent volume - see the full leaderboard. See the ranking
Compare Restor3d, Inc. against Qingdao University of Science and Technology, an assignee filing at a similar volume. Compare portfolios
Innovation Score of 36.2/100 blends volume, velocity, technology breadth, and claim depth. How it's calculated

Figures reflect USPTO PatentsView grant data through May 2026; pending applications not yet granted are not counted.

Data sourced from USPTO PatentsView - official U.S. government patent data. See our methodology for computation details. Retrieved and formatted by PlainPatent

Disclaimer: This information is provided for informational purposes only and does not constitute professional advice. Data is sourced from the USPTO PatentsView database. Consult a qualified professional before making decisions based on this data.

Read our methodology - how this data is sourced, computed, and verified.

Data sources used on this page

USPTO PatentsView - the disambiguated bulk patent-grant, assignee, and CPC data this page's figures are derived from. patentsview.org
Cooperative Patent Classification (CPC) - the joint USPTO/EPO classification scheme used to group patents by technology area. cooperativepatentclassification.org
USPTO Patent Public Search - the official interface to verify the status of any individual patent. ppubs.uspto.gov

Compiled by PlainPatent, US Patent Intelligence Editorial Process · May 15, 2026

Every figure on PlainPatent is rendered directly from USPTO source data, no number is typed in by an editor. This page draws directly on USPTO source data, no figure is typed in by an editor. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error. Data current as of May 2026.